Axis-Shield Ltd Stock

Stocks

Delayed London S.E.			5-day change	1st Jan Change
- ^GBX	-.--%		-.--%	-

20-07-29	Axis Shield : The Effect of Food Intake on the Pharmacokinetics of Vadadustat Following Single Dose Administration	PU
20-07-29	Axis Shield : Randomized, Double-Blinded, Active-Controlled (Darbepoetin Alfa), Phase 3 Study of Vadadustat in Chronic Kidney Disease Patients With Anemia on Hemodialysis in Japan	PU
20-07-29	Axis Shield : Preclinical Characterization of Vadadustat (AKB-6548), an Oral Small Molecule Hypoxia Inducible Factor Prolyl-4-Hydroxylase Inhibitor, for the Potential Treatment of Renal Anemia	PU
20-07-29	Axis Shield : Targeted Literature Review of Patient-reported Burden of Anemia in Chronic Kidney Disease	PU
20-07-29	Efficacy and Safety of Vadadustat, an Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, Being Evaluated for the Treatment of Anemia Due to Chronic Kidney Disease (CKD) in Japanese Subjects: Results from Phase 2 Studies (encore)	PU

Manager	Title	Age	Since
Erling M. H. Sundrehagen CTO	Chief Tech/Sci/R&D Officer	74	1983-12-31
Atle Schjøtt PRN	Corporate Officer/Principal	-	2010-09-19
Guido Schilling PRN	Corporate Officer/Principal	-	2010-09-19

Director	Title	Age	Since
Erling M. H. Sundrehagen BRD	Director/Board Member	74	1983-12-31
Benjamin Edward Oosterbaan BRD	Director/Board Member	63	-
Brian Yoor BRD	Director/Board Member	56	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AXIS-SHIELD LTD	-.--%	-.--%	-	-	0
GUARDANT HEALTH, INC.	+3.39%	+0.75%	+143.86%	+320.70%	21.34B
BIOMÉRIEUX	+1.00%	+1.95%	-36.14%	-20.71%	10.26B
10X GENOMICS, INC.	-3.96%	-5.99%	+328.12%	+15.68%	8.14B
CARIS LIFE SCIENCES, INC.	-2.79%	-5.17%	-35.45%	-	7.2B
LANTHEUS HOLDINGS, INC.	-0.08%	+0.08%	+83.75%	+47.40%	6.59B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	+1.54%	-1.50%	-18.78%	-16.58%	5.83B
ANDON HEALTH CO., LTD.	-1.69%	+2.81%	+75.04%	+86.36%	4.39B
DIASORIN S.P.A.	-0.05%	+0.48%	-12.00%	-22.26%	4.36B
AUTOBIO DIAGNOSTICS CO., LTD.	+0.52%	-2.90%	-18.44%	-27.83%	2.8B
Average	-0.21%	-0.50%	+56.66%	+47.84%	7.09B
Weighted average by Cap.	+0.46%	-1.06%	+81.53%	+112.68%